Live
- Bengal Assembly: BJP stages walkout after MLA's microphone 'disconnected'
- AP Mega DSC Syllabus Released Ahead of issuance of Notification
- Exciting Future Space Missions by ISRO: Venus, Moon, Mars, Human Spaceflight, and More
- Space Station Safety Alert: Toxic Smell Detected After Russian Cargo Docking
- Protests in Tripura against Hindu priest's arrest in Bangladesh
- Sambhal miscreants being identified through CCTV, will face strict action: UP Minister
- Sambhal violence: Police release photos of rioters including three women
- AI-Enhanced HR Co-Pilot Max Sara 2.0 Rolled Out
- Hyderabad SBI Branch Prevents Senior Citizen from Falling Victim to Rs 13 Lakh Scam
- Maharashtra CM Post: Eknath Shinde's Plan B
Sun Pharma Launches Cancer Drug In Europe, Shares Gain
Drug major Sun Pharmaceutical Industries Ltd on Monday announced the launch of ready-to-administer cancer drug Gemcitabine InfuSMART in Europe.In a statement, the company said InfuSMART is a technology in which oncology/cancer products were developed in a ready-to-administer bag.
Drug major Sun Pharmaceutical Industries Ltd on Monday announced the launch of ready-to-administer cancer drug Gemcitabine InfuSMART in Europe.In a statement, the company said InfuSMART is a technology in which oncology/cancer products were developed in a ready-to-administer bag.
"Until now, compounding of oncology products was done at compounding centres or compounded in hospital pharmacies, an extra step before the medicine can be administered to patients," the company said.
Sun Pharma claimed that it is the world's first pharmaceutical company to manufacture and launch a licensed ready-to-administer oncology product.
Over the next few months, Sun Pharma will launch Gemcitabine InfuSMART across Netherlands, Britain, Spain, Germany, Italy and France.
Sun Pharma shares rose over 1 per cent today.
